IMB-881
IMB-881 is an antibacterial agent. IMB-881 binds to LptA to inhibit the interaction between LptA and LptC. IMB-881 shows potent antibacterial activity against Gram-negative bacteria.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 90%
- CAS No.: 501017-82-9
- Formule: C19H17ClN2O
- Masse moléculaire:324.80
-
Stockage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
22.7 μM
Compound: 3
|
Cytotoxicity against human HepG2 cells assessed as growth inhibition by XTT assay
Cytotoxicity against human HepG2 cells assessed as growth inhibition by XTT assay
|
[PMID: 36793433] |
Chemical Information
-
CAS No. 501017-82-9
-
Appearance Solid
-
Masse moléculaire 324.80
-
Formule C19H17ClN2O
-
Color White to off-white
-
SMILES
ClC(C1=CC=CN=C12)=CC3=C2OCN(CCC4=CC=CC=C4)C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Pureté et documentation
-
Fiche technique (267 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Korean - KR (396 KB)
- Portuguese - PT (396 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Liu C, et al. Synthesis, biological evaluation and validation of IMB-881 derivatives as anti-Gram-negative bacterial agents. Bioorg Med Chem. 2025 Mar 1;119:118066. [Content Brief]
[2]. Zhang X, et al. Identification of an anti-Gram-negative bacteria agent disrupting the interaction between lipopolysaccharide transporters LptA and LptC. Int J Antimicrob Agents. 2019 Apr;53(4):442-448. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)